This report contains market size and forecasts of Genomic Testing in Cancer in Global, including the following market information:
Global Genomic Testing in Cancer Market Size 2024-2029, ($ millions)
The global Genomic Testing in Cancer market is projected to reach US$ million by 2029.
We surveyed the Genomic Testing in Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomic Testing in Cancer Market, by Type, 2024-2029 ($ millions)
Global Genomic Testing in Cancer Market Segment Percentages, by Type
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Global Genomic Testing in Cancer Market, by Application, 2024-2029 ($ millions)
Global Genomic Testing in Cancer Market Segment Percentages, by Application
General Hospitals
Specialty Clinics
Global Genomic Testing in Cancer Market, By Region and Country, 2024-2029 ($ Millions)
Global Genomic Testing in Cancer Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genomic Testing in Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genomic Testing in Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genomic Testing in Cancer Overall Market Size
2.1 Global Genomic Testing in Cancer Market Size: 2023 VS 2029
2.2 Global Genomic Testing in Cancer Market Size, Prospects & Forecasts: 2023-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Genomic Testing in Cancer Players in Global Market
3.2 Global Companies Genomic Testing in Cancer Product & Technology
4 Genomic Testing in Cancer Companies Profiles
4.1 23andMe
4.1.1 23andMe Company Summary
4.1.2 23andMe Business Overview
4.1.3 23andMe Genomic Testing in Cancer Product Offerings & Technology
4.1.4 23andMe Genomic Testing in Cancer R&D, and Plans
4.2 Agilent Technologies
4.2.1 Agilent Technologies Company Summary
4.2.2 Agilent Technologies Business Overview
4.2.3 Agilent Technologies Genomic Testing in Cancer Product Offerings & Technology
4.2.4 Agilent Technologies Genomic Testing in Cancer R&D, and Plans
4.3 Bio-Rad Laboratories
4.3.1 Bio-Rad Laboratories Company Summary
4.3.2 Bio-Rad Laboratories Business Overview
4.3.3 Bio-Rad Laboratories Genomic Testing in Cancer Product Offerings & Technology
4.3.4 Bio-Rad Laboratories Genomic Testing in Cancer R&D, and Plans
4.4 Centogene
4.4.1 Centogene Company Summary
4.4.2 Centogene Business Overview
4.4.3 Centogene Genomic Testing in Cancer Product Offerings & Technology
4.4.4 Centogene Genomic Testing in Cancer R&D, and Plans
4.5 Color Genomics
4.5.1 Color Genomics Company Summary
4.5.2 Color Genomics Business Overview
4.5.3 Color Genomics Genomic Testing in Cancer Product Offerings & Technology
4.5.4 Color Genomics Genomic Testing in Cancer R&D, and Plans
4.6 Gene By Gene
4.6.1 Gene By Gene Company Summary
4.6.2 Gene By Gene Business Overview
4.6.3 Gene By Gene Genomic Testing in Cancer Product Offerings & Technology
4.6.4 Gene By Gene Genomic Testing in Cancer R&D, and Plans
4.7 Illumina
4.7.1 Illumina Company Summary
4.7.2 Illumina Business Overview
4.7.3 Illumina Genomic Testing in Cancer Product Offerings & Technology
4.7.4 Illumina Genomic Testing in Cancer R&D, and Plans
4.8 LabCorp
4.8.1 LabCorp Company Summary
4.8.2 LabCorp Business Overview
4.8.3 LabCorp Genomic Testing in Cancer Product Offerings & Technology
4.8.4 LabCorp Genomic Testing in Cancer R&D, and Plans
4.9 Myriad Genetics
4.9.1 Myriad Genetics Company Summary
4.9.2 Myriad Genetics Business Overview
4.9.3 Myriad Genetics Genomic Testing in Cancer Product Offerings & Technology
4.9.4 Myriad Genetics Genomic Testing in Cancer R&D, and Plans
4.10 Positive Bioscience
4.10.1 Positive Bioscience Company Summary
4.10.2 Positive Bioscience Business Overview
4.10.3 Positive Bioscience Genomic Testing in Cancer Product Offerings & Technology
4.10.4 Positive Bioscience Genomic Testing in Cancer R&D, and Plans
4.11 Quest Diagnostics
4.11.1 Quest Diagnostics Company Summary
4.11.2 Quest Diagnostics Business Overview
4.11.3 Quest Diagnostics Genomic Testing in Cancer Product Offerings & Technology
4.11.4 Quest Diagnostics Genomic Testing in Cancer R&D, and Plans
4.12 Thermo Fisher Scientific
4.12.1 Thermo Fisher Scientific Company Summary
4.12.2 Thermo Fisher Scientific Business Overview
4.12.3 Thermo Fisher Scientific Genomic Testing in Cancer Product Offerings & Technology
4.12.4 Thermo Fisher Scientific Genomic Testing in Cancer R&D, and Plans
5 Sights by Region
5.1 By Region - Global Genomic Testing in Cancer Market Size, 2024 & 2029
5.2 By Region - Global Genomic Testing in Cancer Revenue, (2024-2029)
5.3 United States
5.3.1 Key Players of Genomic Testing in Cancer in United States
5.3.2 United States Genomic Testing in Cancer Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Genomic Testing in Cancer in Europe
5.4.2 Europe Genomic Testing in Cancer Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Genomic Testing in Cancer in China
5.5.2 China Genomic Testing in Cancer Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Genomic Testing in Cancer Market Size Markets, 2024 & 2029
6.2 Breast Cancer
6.3 Lung Cancer
6.4 Blood Cancer
6.5 Liver Cancer
6.6 Stomach Cancer
6.7 Others
7 Sights by Application
7.1 By Application - Global Genomic Testing in Cancer Market Size, 2024 & 2029
7.2 General Hospitals
7.3 Specialty Clinics
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genomic Testing in Cancer Market Opportunities & Trends in Global Market
Table 2. Genomic Testing in Cancer Market Drivers in Global Market
Table 3. Genomic Testing in Cancer Market Restraints in Global Market
Table 4. Key Players of Genomic Testing in Cancer in Global Market
Table 5. Global Companies Genomic Testing in Cancer Product & Technology
Table 6. 23andMe Company Summary
Table 7. 23andMe Genomic Testing in Cancer Product Offerings
Table 8. Agilent Technologies Company Summary
Table 9. Agilent Technologies Genomic Testing in Cancer Product Offerings
Table 10. Bio-Rad Laboratories Company Summary
Table 11. Bio-Rad Laboratories Genomic Testing in Cancer Product Offerings
Table 12. Centogene Company Summary
Table 13. Centogene Genomic Testing in Cancer Product Offerings
Table 14. Color Genomics Company Summary
Table 15. Color Genomics Genomic Testing in Cancer Product Offerings
Table 16. Gene By Gene Company Summary
Table 17. Gene By Gene Genomic Testing in Cancer Product Offerings
Table 18. Illumina Company Summary
Table 19. Illumina Genomic Testing in Cancer Product Offerings
Table 20. LabCorp Company Summary
Table 21. LabCorp Genomic Testing in Cancer Product Offerings
Table 22. Myriad Genetics Company Summary
Table 23. Myriad Genetics Genomic Testing in Cancer Product Offerings
Table 24. Positive Bioscience Company Summary
Table 25. Positive Bioscience Genomic Testing in Cancer Product Offerings
Table 26. Quest Diagnostics Company Summary
Table 27. Quest Diagnostics Genomic Testing in Cancer Product Offerings
Table 28. Thermo Fisher Scientific Company Summary
Table 29. Thermo Fisher Scientific Genomic Testing in Cancer Product Offerings
Table 30. By Region? Global Genomic Testing in Cancer Revenue, (US$, Mn), 2024 & 2029
Table 31. By Region - Global Genomic Testing in Cancer Revenue, (US$, Mn), 2024-2029
Table 32. By Type ? Global Genomic Testing in Cancer Market Size, (US$, Mn), 2024 & 2029
Table 33. By Application? Global Genomic Testing in Cancer Market Size, (US$, Mn), 2024 & 2029
List of Figures
Figure 1. Genomic Testing in Cancer Segment by Type in 2029
Figure 2. Genomic Testing in Cancer Segment by Application in 2029
Figure 3. Global Genomic Testing in Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Genomic Testing in Cancer Market Size: 2023 VS 2029 (US$, Mn)
Figure 6. Global Genomic Testing in Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Genomic Testing in Cancer Revenue Market Share, 2024-2029
Figure 8. By Type - Global Genomic Testing in Cancer Revenue Market Share, 2024-2029
Figure 9. By Application - Global Genomic Testing in Cancer Revenue Market Share, 2024-2029
